{
    "Trade/Device Name(s)": [
        "QuickProfile Single Drugs of Abuse Screen Device",
        "QuickProfile Multi-Drugs of Abuse Screen Device"
    ],
    "Submitter Information": "LumiQuick Diagnostics, Inc.",
    "510(k) Number": "K130213",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061718"
    ],
    "Regulatory Class": "Class II, Unclassified (PCP)",
    "Product Code(s)": [
        "LDJ",
        "DIO",
        "LCM",
        "DKZ",
        "JXM",
        "DJG",
        "DJC",
        "DJR",
        "DIS"
    ],
    "Summary Letter Date": "August 29, 2013",
    "Summary Letter Received Date": "September 6, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3870",
        "21CFR862.3250",
        "21CFR862.3650",
        "21CFR862.3100",
        "21CFR862.3170",
        "21CFR862.3610",
        "21CFR862.3620",
        "21CFR862.3150"
    ],
    "Regulation Name(s)": [
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Benzoylecgonine",
        "Methadone",
        "Methamphetamine",
        "Morphine",
        "Phencyclidine",
        "THC (11-nor-\u03949-THC-9-COOH)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Colloidal gold based chromatographic immunoassay",
        "Immunoassay"
    ],
    "Methodologies": [
        "Rapid chromatographic immunoassay"
    ],
    "Submission Type(s)": [
        "Test strip",
        "Dip panel",
        "Cassette panel",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for QuickProfile Single and Multi-Drugs of Abuse Screen Devices for rapid qualitative urine detection of multiple drugs of abuse using immunoassay technology.",
    "Indications for Use Summary": "Qualitative and simultaneous prescription-use detection of up to nine drugs of abuse in human urine; provides preliminary analytical results requiring confirmatory chemical testing.",
    "fda_folder": "Toxicology"
}